ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MBIO Mustang Bio Inc

0.2658
0.0057 (2.19%)
After Hours
Last Updated: 18:27:45
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Mustang Bio Inc MBIO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0057 2.19% 0.2658 18:27:45
Open Price Low Price High Price Close Price Previous Close
0.2699 0.2699 0.2999 0.293 0.2601
more quote information »

Recent News

Date Time Source Heading
5/02/202415:01GLOBEMustang Bio Announces Closing of $4 Million Public Offering
4/29/202419:00GLOBEMustang Bio Announces Pricing of $4 Million Public Offering
3/28/202408:00GLOBEMustang Bio Announces Vision for CAR T-Cell Therapy Platform..
3/11/202415:30EDGAR2Form 8-K - Current report
3/11/202415:05GLOBEMustang Bio Reports Full-Year 2023 Financial Results and..
3/11/202415:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/07/202406:30GLOBEMustang Bio Announces Publication in Nature Medicine of Data..
2/14/202415:15EDGAR2Form 8-K - Current report
1/25/202415:07EDGAR2Form 8-K - Current report
1/11/202407:30GLOBEMustang Bio to Participate in the B. Riley Securities 4th..
1/04/202415:05EDGAR2Form 8-K - Current report
12/19/202315:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/11/202320:52EDGAR2Form S-1 - General form for registration of securities under..
12/11/202307:37EDGAR2Form 8-K - Current report
12/11/202307:30GLOBEMustang Bio Presents Updated Phase 1/2 Multicenter Clinical..
11/14/202315:44EDGAR2Form 8-K - Current report
11/14/202315:05GLOBEMustang Bio Reports Third Quarter 2023 Financial Results and..
11/03/202314:22EDGAR2Form D - Notice of Exempt Offering of Securities
11/02/202315:05EDGAR2Form 8-K - Current report
11/02/202308:28GLOBEMustang Bio Announces MB-106 CD20-Targeted CAR-T Data..
10/30/202313:57EDGAR2Form 8-K - Current report
10/30/202313:15GLOBEMustang Bio Announces Closing of $4.4 Million Registered..
10/30/202309:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/26/202315:05EDGAR2Form 8-K - Current report
10/26/202311:30GLOBEMustang Bio Announces $4.4 Million Registered Direct..
10/26/202308:00GLOBEMustang Bio Announces FDA Acceptance of IND Application for..
10/04/202315:05EDGAR2Form 8-K - Current report
8/16/202307:56EDGAR2Form 8-K - Current report
8/14/202315:10EDGAR2Form 8-K - Current report
8/14/202315:01GLOBEFortress Biotech Reports Second Quarter 2023 Financial..
8/14/202315:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/31/202307:40EDGAR2Form 8-K - Current report
7/20/202316:30EDGAR2Form 8-K - Current report
7/11/202307:05EDGAR2Form 8-K - Current report
7/07/202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/30/202307:05EDGAR2Form 8-K - Current report
5/15/202315:01GLOBEFortress Biotech Reports First Quarter 2023 Financial..

Your Recent History

Delayed Upgrade Clock